Checkmate Pharmaceuticals (CMPI) Stock Price, News & Analysis
Company Description
Checkmate Pharmaceuticals (NASDAQ: CMPI) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $231.4M.
This page collects what Stock Titan holds for CMPI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
Checkmate Pharmaceuticals has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, earnings, acquisition, conferences, management. View all CMPI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CMPI Company Profile & Sector Positioning
Checkmate Pharmaceuticals (CMPI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing CMPI often look at related companies in the same sector, including Voyager Therapeutics Inc (VYGR), Third Harmonic Bio Inc (THRD), AC Immune (ACIU), Humacyte Inc (HUMA), and Proqr Therapeuti (PRQR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CMPI's relative position within its industry.